PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.93%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
32.45%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
15.67%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-2.74%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
2.61%
R&D change of 2.61% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
48.47%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
29.76%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
22.71%
Operating expenses growth 1.25-1.5x CRWV's 17.97%. Martin Whitman would scrutinize control.
26.03%
Total costs growth 1.25-1.5x CRWV's 18.28%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
10.57%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
9.51%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-8.77%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
9.51%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
-7.92%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
13.76%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
9.72%
Similar pre-tax income growth to CRWV's 9.63%. Walter Schloss would investigate industry trends.
-7.75%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
9.65%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
9.75%
Net income growth 1.25-1.5x CRWV's 7.67%. Bruce Berkowitz would examine sustainability.
-7.72%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
8.70%
EPS growth below 50% of CRWV's 23.08%. Michael Burry would check for structural issues.
11.11%
Diluted EPS growth below 50% of CRWV's 23.08%. Michael Burry would check for structural issues.
-0.20%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.11%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.